Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

epithelial-mesenchymal transition

  • You have access
    Sialic Acid-Fibronectin-negative and Vimentin-positive Breast Cancers Have Poor Prognoses due to Epithelial-Mesenchymal Transition
    HIROSHI TAKEYAMA, YOSHINOBU MANOME, MUNEYUKI KOYAMA, YUKIKO YOSHII, ERIKO TAGUCHI, AZUSA FUKE, TAKAAKI YAMASHITA, YOSHINOBU FUSE, ATUSHI FUSHIMI and HIROKO NOGI
    Anticancer Research April 2025, 45 (4) 1617-1629; DOI: https://doi.org/10.21873/anticanres.17543
  • You have access
    Thyroid Cancer With Autocrine Sialyl-fibronectin Depletion Has a Poor Prognosis due to EMT Progression
    RYO MIYAKE, HIROSHI TAKEYAMA, YOSHINOBU MANOME, MUNEYUKI KOYAMA, ISAO TABEI, HISASHI SHIOYA, TAKASHI KAZAMA and HIROKO NOGI
    Anticancer Research October 2024, 44 (10) 4561-4568; DOI: https://doi.org/10.21873/anticanres.17285
  • You have access
    Indoleamine 2,3-Dioxygenase Inhibitor Suppresses Colon Cancer Cell Migration, Invasion, and Epithelial-Mesenchymal Transition
    YUMI YOKOTA, HIROAKI NOZAWA, HIROFUMI SONODA, YUICHIRO YOKOYAMA, SHIGENOBU EMOTO, KOJI MURONO, KAZUHITO SASAKI and SOICHIRO ISHIHARA
    Anticancer Research August 2024, 44 (8) 3337-3342; DOI: https://doi.org/10.21873/anticanres.17153
  • You have access
    The Oncological Effect of Mutant p53 on the Metastatic Phenotype of Gastric Cancer Cells
    HIROSHI KITAGAWA, MASATSUGU HIRAKI, TAKUSHI NAMBA, KOICHI BABA, SHUUSUKE MIYAKE, KOTARO ITO, TOMOKAZU TANAKA and HIROKAZU NOSHIRO
    Anticancer Research November 2023, 43 (11) 4887-4895; DOI: https://doi.org/10.21873/anticanres.16686
  • You have access
    Epithelial–Mesenchymal Transition Phenotype and Peritumoral Immune Cell Infiltration in Advanced Biliary Tract Cancer
    CHUNG RYUL OH, HYUNG-DON KIM, YEON-MI RYU, SEONMIN LEE, DANBEE KIM, DA SOL LEE, JAE HO JEONG, HEUNG-MOON CHANG, BAEK-YEOL RYOO, KYU-PYO KIM, MIYEON KIM, SANG-YEOB KIM and CHANGHOON YOO
    Anticancer Research February 2023, 43 (2) 645-652; DOI: https://doi.org/10.21873/anticanres.16201
  • Open Access
    Immunological and Genetic Characterization of Patients With Head and Neck Cancer who Developed Recurrence
    KAZUAKI YASUI, RYOTA KONDOU, HARUO MIYATA, AKIRA IIZUKA, TADASHI ASHIZAWA, TAKESHI NAGASHIMA, KEIICHI OHSHIMA, KENICHI URAKAMI, KOJI MURAMATSU, TAKASHI SUGINO, KEN YAMAGUCHI, HIROFUMI OGAWA, TSUYOSHI ONOE, HIDEYUKI HARADA, HIROFUMI ASAKURA, SHIGEYUKI MURAYAMA, TETSUO NISHIMURA, SEIYA GOTO, SHINICHI OKADA, TAKASHI MUKAIGAWA, SATOSHI HAMAUCHI, TOMOYA YOKOTA, YUSUKE ONOZAWA and YASUTO AKIYAMA
    Anticancer Research September 2022, 42 (9) 4417-4428; DOI: https://doi.org/10.21873/anticanres.15942
  • You have access
    Anti-tumor Effect of Hedgehog Signaling Inhibitor, Vismodegib, on Castration-resistant Prostate Cancer
    AYA ISHII, KATSUMI SHIGEMURA, KOICHI KITAGAWA, SHIAN-YING SUNG, KUAN-CHOU CHEN, CHIANG YI-TE, MING-CHE LIU and MASATO FUJISAWA
    Anticancer Research September 2020, 40 (9) 5107-5114; DOI: https://doi.org/10.21873/anticanres.14514
  • You have access
    Exploration of Exosomal Micro RNA Biomarkers Related to Epithelial-to-Mesenchymal Transition in Pancreatic Cancer
    FUMINORI SONOHARA, SUGURU YAMADA, SHIGEOMI TAKEDA, MASAMICHI HAYASHI, MASAYA SUENAGA, YUKI SUNAGAWA, MITSURU TASHIRO, HIDEKI TAKAMI, MITSURO KANDA, CHIE TANAKA, DAISUKE KOBAYASHI, GORO NAKAYAMA, MASAHIKO KOIKE, MICHITAKA FUJIWARA and YASUHIRO KODERA
    Anticancer Research April 2020, 40 (4) 1843-1853; DOI: https://doi.org/10.21873/anticanres.14138
  • You have access
    The Effects of Eribulin on Breast Cancer Microenvironment Identified Using Eribulin-resistant Breast Cancer Cell Lines
    WATARU GOTO, SHINICHIRO KASHIWAGI, YUKA ASANO, KOJI TAKADA, KATSUYUKI TAKAHASHI, HISAKAZU FUJITA, TSUTOMU TAKASHIMA, MASATSUNE SHIBUTANI, RYOSUKE AMANO, SHUHEI TOMITA, KOSEI HIRAKAWA and MASAICHI OHIRA
    Anticancer Research August 2019, 39 (8) 4031-4041; DOI: https://doi.org/10.21873/anticanres.13559
  • You have access
    Twist1 Correlates With Epithelial-Mesenchymal Transition Markers Fibronectin and Vimentin in Adrenocortical Tumors
    DANIEL BULZICO, BRUNO RICARDO BARRETO PIRES, PAULO ANTÔNIO SILVESTRE DE FARIA, LEONARDO VIEIRA NETO and ELIANA ABDELHAY
    Anticancer Research January 2019, 39 (1) 173-175; DOI: https://doi.org/10.21873/anticanres.13094

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire